Literature DB >> 30878258

Increased perioperative C-reactive protein and decreased postoperative albumin is associated with acute posttraumatic osteomyelitis in patients with high-energy tibial fractures.

Matjaž Groznik1, Matej Cimerman2, Lara Lusa3, Nina Ružić Gorenjec4, Alojz Ihan5.   

Abstract

BACKGROUND: Early diagnosis of acute posttraumatic osteomyelitis (POM) is of vital importance for avoiding devastating complications. Diagnosing POM is difficult due to the lack of a highly specific and sensitive test, such as in myocardial infarct, stroke and intracranial bleeding. Serum inflammatory markers, C-reactive protein (CRP), procalcitonin (PCT), white blood cells (WBC) can support clinical findings but they are not able to differentiate between inflammatory response to infection and the host response to non-infection insult with high specificity and sensitivity. AIM: The objectives of the study were to investigate whether the biochemical and immunoinflammatory patient profile could facilitate postoperative monitoring, guide the antibiotic treatment and timing of revision surgery. PATIENTS AND METHODS: This prospective nonrandomised cohort study included 86 patients after high-energy injury to the shin requiring primary surgical treatment (open or closed reduction and internal fixation of tibial fracture). Values of the biochemical and immunoinflammatory profile were measured on admission (ADD), first postoperative day (POD1) and fourth-postoperative day (POD4).
RESULTS: We discovered on our sample that the development of POM is associated with increased CRP on ADD, POD1 and decreased albumins on POD4. Further studies are needed to prove that these differences can be useful in diagnosing the risk of infection. The assessment of other important risk factors such as: the extent of soft tissue damage, multiple fractures, transfusion rate, need for conversion primary external fixation to intramedullary (IM) nailing or locking plate fixation can empower our clinical judgment of POM.
CONCLUSIONS: We can improve prediction of posttraumatic osteomyelitis by using the perioperative inflammatory biomarker CRP in combination with postoperative albumins levels and other associated independent risk factors.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Albumin; CRP; Cytokines; PCT; Posttraumatic osteomyelitis; T regulatory cells CD4+CD25+; Tibial fracture

Year:  2019        PMID: 30878258     DOI: 10.1016/j.injury.2019.02.019

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  4 in total

1.  Comparative diagnostic accuracy of respective nuclear imaging for suspected fracture-related infection: a systematic review and Bayesian network meta-analysis.

Authors:  Qingyu Zhang; Jinlei Dong; Yelong Shen; Canhua Yun; Dongsheng Zhou; Fanxiao Liu
Journal:  Arch Orthop Trauma Surg       Date:  2020-06-08       Impact factor: 3.067

2.  Serology and Comorbidities in Patients With Fracture Nonunion: A Multicenter Evaluation of 640 Patients.

Authors:  Joshua A Shapiro; Matthew R Stillwagon; Paul Tornetta; Thomas M Seaver; Mark Gage; Jeffrey O'Donnell; Keith Whitlock; Seth R Yarboro; Kyle J Jeray; William T Obremskey; Andres Rodriguez-Buitrago; Paul Matuszewski; Feng-Chang Lin; Robert F Ostrum
Journal:  J Am Acad Orthop Surg       Date:  2022-06-07       Impact factor: 4.000

3.  Retrospective Analysis of Infection Factors in Secondary Internal Fixation after External Fixation for Open Fracture of a Long Bone: A Cohort of 117 Patients in a Two-Center Clinical Study.

Authors:  Shanwen Zhao; Zelin Ye; Canjun Zeng; Lei Zhang; Juanyu Huang; Wensheng Zhang; Runguang Li
Journal:  Biomed Res Int       Date:  2022-06-30       Impact factor: 3.246

4.  The Investigation on Nosocomial Infection of Acinetobacter baumannii and the Clinical Analysis of Sequential Therapy of Cefoperazone/Sulbactam Sodium for Intracranial Infection.

Authors:  Zezhong Xiong; Defu Zeng; Shilong Shen; Zhibang Han
Journal:  Comput Math Methods Med       Date:  2022-08-16       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.